Bi-Modified Bi₂WO₆/BiOI Heterojunction with Enhanced Visible-Light-Driven Photoactivity for Antibiotic Degradation

Figure 8

TOC removal during CIP (20 mg/L, 50 mL) and LEV (20 mg/L, 50 mL) degradation in the presence of 20% Bi-Bi₂WO₆/BiOI (50 mg, 40 mg).